EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Formosa Optical Technology Co Ltd (5312) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Formosa Optical Technology Co Ltd TWD 108, price TWD 90.50, upside +19.8%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · TW · ISIN TW0005312003

FO Broad data Sep 24, 2026

Formosa Optical Technology Co Ltd

5312 · TWO

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value 108.41 TWD · Undervalued (+20%)
!Quality 54/100
✓Healthy Growth (revenue 5y +6.2 %/yr)
!Thin margins · 8.3% net margin (TTM)
✓Low debt · generates free cash flow
·7.18% dividend yield
✓Ranks above peers (11/14)
!Narrow moat 44/100
!Insider activity 45/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

148.44 TWD 41.47 TWD Fair Value 108.41 TWD Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 41.47 TWD – 148.44 TWD · fair‑value band 81.31 TWD – 135.51 TWD · the 90.50 TWD price screens below the 108.41 TWD fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Formosa Optical Technology Co in your weekly email

Every Wednesday you see whether Formosa Optical Technology Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Formosa Optical Technology Co.,Ltd. provides eyecare products in Taiwan. The company provides optical glasses, frames, sunglasses, contact transparent lenses, and color contact lenses. It also offers eye drops and optometry equipment. The company was founded in 1976 and is based in New Taipei City, Taiwan.

Stock analysis

Formosa Optical Technology Co Ltd (5312) currently trades at 90.50 TWD, while our model-based Fair Value estimate is 108.41 TWD, implying the stock looks roughly 16.5% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 120.51 TWD per share, and 12 of the 26 models we run sit above the 90.50 TWD price.

Bear case: the Economic Profit group reads lowest at 27.88 TWD, and 14 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 81.31 TWD (bear) to 135.51 TWD (bull), the price of 90.50 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Formosa Optical Technology Co Ltd reported revenue of 4.1B TWD in FY2025 versus 2.9B TWD in FY2021, a compound +9.1%/yr. Reported net income was 385M TWD in FY2025, compounding +7.4%/yr from FY2021.

Key figures

Market cap 6.0B TWD (≈ $189M) · P/E ratio 14.1 · P/S ratio 1.32 · EPS (TTM) 6.40 TWD · Dividend yield 7.2% · Net margin 9.3% · Return on equity 9.5% · Return on assets (EBIT) 5.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 10% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at 20%, 5312 screens cheaper than that median.

Fair Value models

Bear 81.31 TWD Fair Value 108.41 TWD Bull 135.51 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 76.43 TWD 103.93 TWD 137.30 TWD 81
Growth DCF 76.83 TWD 100.93 TWD 128.57 TWD 80
Owner Earnings 90.43 TWD 122.89 TWD 162.29 TWD 77
All 26 models by family
DCF Models
FCF DCF 76.43 TWD 103.93 TWD 137.30 TWD 81
Owner Earnings 90.43 TWD 122.89 TWD 162.29 TWD 77
5Y Revenue Exit 56.92 TWD 80.19 TWD 108.43 TWD 73
5Y EBITDA Exit 95.52 TWD 150.91 TWD 214.10 TWD 75
5Y P/E Exit 84.95 TWD 131.54 TWD 179.11 TWD 71
10Y Revenue Exit 63.95 TWD 84.91 TWD 110.62 TWD 68
10Y EBITDA Exit 85.84 TWD 126.42 TWD 178.21 TWD 68
10Y P/E Exit 80.11 TWD 115.05 TWD 155.83 TWD 64
Earnings-Based
Graham-Dodd 43.62 TWD 123.19 TWD 162.17 TWD 65
Lynch FV 25.01 TWD 35.73 TWD 46.45 TWD 61
PEG = 1.0 25.01 TWD 35.73 TWD 46.45 TWD 57
EPV 24.77 TWD 27.88 TWD 30.39 TWD 74
Dividend Discount
Gordon GGM 52.24 TWD 87.50 TWD 113.57 TWD 68
DDM Multi-Stage 52.24 TWD 75.48 TWD 94.13 TWD 67
Multiples
P/E Multiple 105.84 TWD 141.13 TWD 176.41 TWD 63
P/S Multiple 61.87 TWD 82.49 TWD 103.11 TWD 58
P/B Multiple 81.79 TWD 109.05 TWD 136.32 TWD 55
EV/EBIT 66.10 TWD 88.50 TWD 110.89 TWD 66
EV/EBITDA 126.39 TWD 168.88 TWD 211.37 TWD 67
EV/Revenue 44.21 TWD 63.62 TWD 83.02 TWD 53
Asset-Based
NCAV (Graham) 31.04 TWD 41.60 TWD 62.08 TWD 54
Growth DCF
Growth DCF 76.83 TWD 100.93 TWD 128.57 TWD 80
Rev-Margin DCF 56.92 TWD 81.45 TWD 109.37 TWD 73
Economic Profit
Residual Income 50.24 TWD 54.24 TWD 59.87 TWD 76
ROIC Compounder 24.77 TWD 27.88 TWD 30.39 TWD 72
Growth Earnings
Growth-Adj P/E 84.36 TWD 120.51 TWD 156.67 TWD 67

Open the full fair value analysis →

Notify me when 5312 reaches fair value

Put 5312 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 54/100

Of which business quality 54 · Market factors (momentum, volatility) 47

Profitability 41
Margins and returns on capital today
Quality Growth 49
Are margins and returns improving?
Cashflow 70
Earnings quality: real cash, not paper profit
Fin. Strength 41
Balance sheet, leverage, solvency risk
Investment 47
Disciplined investing over empire-building
Low Volatility 91
Calm price path (market factor)
Momentum 35
Price trend over the last 3–12 months (market factor)
52W Momentum 19
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 72/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+3.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
Start year 2020 (pandemic). Over 10 years: +5.0% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+11.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.6%
Dividend (yield on the price)7.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 7%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−1.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about −2.6% a year for the price.

Watch 5312, get fair value alerts →

Compare Formosa Optical Technology Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks

Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 54 · Below median
Fair Value upside +20% · Top 25%
Profitability
Return on equity (TTM) 9% · Above median
Return on assets 2% · Below median
Net margin (TTM) 8% · Above median
Operating margin (TTM) 7% · Below median
Growth and dividend
Revenue growth 12% · Above median
Dividend yield (TTM) 7.2% · Top 25%
Balance sheet
Debt / equity 0.08× · Below median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (TTM) 14.1× · Cheapest 25%
P/B 1.61× · Cheaper than median
P/S (TTM) 1.41× · Cheaper than median
P/FCF 0.4× · Cheapest 25%
EV/EBITDA 12.1× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)60 · sector 17
FUTURE (revenue growth)62 · sector 31
PAST (return on equity)38 · sector 25
HEALTH (low debt)96 · sector 96
DIVIDEND (yield)100 · sector 33

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.09 $353.38 −12%
EssilorLuxottica Société anonyme EL €144.70 €159.17 +10%
Medline Inc MDLN $34.30 $30.15 −12%
Becton, Dickinson and Company BDX $182.52 $103.53 −43%
Alcon Inc ALC $65.39 $39.78 −39%
ResMed Inc RMD A$31.70 A$34.87 +10%
West Pharmaceutical Services, Inc WST $375.87 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €215.80 €54.82 −75%
Straumann Holding STMN CHF 96.38 CHF 45.50 −53%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Formosa Optical Technology Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/5312

Frequently asked questions

Is Formosa Optical Technology Co Ltd (5312) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 108.41 TWD versus a price of 90.50 TWD, about +20% upside (undervalued).
What is the fair value of 5312?
Our model-based fair value for Formosa Optical Technology Co Ltd is 108.41 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 90.50 TWD.
What is the quality score of 5312?
Formosa Optical Technology Co Ltd has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Formosa Optical Technology Co Ltd (5312)?
Our model-based price target is the fair value of 108.41 TWD (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 81.31 TWD, optimistic scenario 135.51 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Formosa Optical Technology Co Ltd stock forecast for 2026?
Our models put fair value at 108.41 TWD, about +20% upside versus a price of 90.50 TWD (undervalued). Cautious scenario 81.31 TWD, optimistic scenario 135.51 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Formosa Optical Technology Co Ltd (5312)?
Formosa Optical Technology Co Ltd reported trailing-twelve-month revenue of about 4.3B TWD (latest available figure, as of Sep 24, 2026).
Does Formosa Optical Technology Co Ltd pay a dividend?
Formosa Optical Technology Co Ltd currently shows a dividend yield of about 7.18% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Formosa Optical Technology Co Ltd (5312)?
For today's price to be fair in a discounted-cash-flow model, Formosa Optical Technology Co Ltd would have to grow free cash flow by -1.1 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 5312 use?
Our models discount Formosa Optical Technology Co Ltd at 11.8 %: a base by market capitalisation (micro), damped by beta 0.01, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Formosa Optical Technology Co Ltd that is -1.1 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Formosa Optical Technology Co Ltd (5312) delivered so far?
Over the past 5 years revenue at Formosa Optical Technology Co Ltd grew +6.2 % a year. The price currently implies -1.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Formosa Optical Technology Co Ltd (5312) growing?
The median revenue growth in the sector is +2.6 % a year. That is the yardstick for the growth priced into Formosa Optical Technology Co Ltd (-1.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Formosa Optical Technology Co Ltd (5312)?
The free-cash-flow yield on the price is 9.77 %: that much free cash flow Formosa Optical Technology Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Formosa Optical Technology Co Ltd (5312)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Formosa Optical Technology Co Ltd it is 108.41 TWD per share (as of Sep 24, 2026), against a price of 90.50 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Formosa Optical Technology Co Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 5312 trades below its calculated fair value: price 90.50 TWD, fair value 108.41 TWD, a gap of about +20% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5312?
No. The price is what the market pays today (90.50 TWD); the fair value is what the company's own numbers justify (108.41 TWD). For Formosa Optical Technology Co Ltd the two are 17.91 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Formosa Optical Technology Co Ltd worth?
The market values Formosa Optical Technology Co Ltd at about 6.0B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 90.50 TWD; our models calculate a fair value of 108.41 TWD per share.
What do the bullish and bearish scenarios say about 5312?
Our models span a range for Formosa Optical Technology Co Ltd: cautious scenario 81.31 TWD, base 108.41 TWD, optimistic 135.51 TWD per share (as of Sep 24, 2026, price 90.50 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 5312?
Formosa Optical Technology Co Ltd trades at a price-to-earnings ratio of 14.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 108.41 TWD is built from several models across several years. Other multiples: P/B 1.6, P/S 1.4, EV/EBITDA 12.1.
How solid is the balance sheet of Formosa Optical Technology Co Ltd (5312)?
Balance-sheet figures for Formosa Optical Technology Co Ltd (as of Sep 24, 2026): return on equity 9.5%, debt of 0.08 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is 5312 from its 52-week high?
Formosa Optical Technology Co Ltd trades at 90.50 TWD, about 10% below its 52-week high of 100.50 TWD and 4% above the low of 87.02 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 108.41 TWD is for.
Which stocks are comparable to Formosa Optical Technology Co Ltd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Formosa Optical Technology Co Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 90.50 TWD, calculated fair value 108.41 TWD (+20%), Quality Score 54/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5312 calculated?
We run Formosa Optical Technology Co Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 108.41 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Formosa Optical Technology Co Ltd currently trades 20 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Formosa Optical Technology Co Ltd (5312)?
The closing price on Sep 24, 2026 was 90.50 TWD. Our model-based fair value is 108.41 TWD, about +20% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Formosa Optical Technology Co Ltd right now?
The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.

Key figures of Formosa Optical Technology Co Ltd

How large is the market capitalisation of Formosa Optical Technology Co Ltd (5312)?
The market capitalisation of Formosa Optical Technology Co Ltd is 6.0B TWD (≈ $189M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Formosa Optical Technology Co Ltd (5312)?
The price-to-sales ratio of Formosa Optical Technology Co Ltd is 1.32 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Formosa Optical Technology Co Ltd (5312)?
Earnings per share at Formosa Optical Technology Co Ltd are 6.40 TWD (price ÷ EPS = P/E 14.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Formosa Optical Technology Co Ltd (5312)?
The dividend yield of Formosa Optical Technology Co Ltd is 7.2% (payout 102%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Formosa Optical Technology Co Ltd (5312)?
The net margin of Formosa Optical Technology Co Ltd is 9.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Formosa Optical Technology Co Ltd (5312)?
The return on equity (ROE) of Formosa Optical Technology Co Ltd is 9.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Formosa Optical Technology Co Ltd (5312)?
On an EBIT basis the return on assets of Formosa Optical Technology Co Ltd is 5.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Formosa Optical Technology Co Ltd (5312)?
The operating margin of Formosa Optical Technology Co Ltd is 6.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Formosa Optical Technology Co Ltd (5312)?
Revenue at Formosa Optical Technology Co Ltd is growing +12.3% versus a year earlier (3y avg +7.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Formosa Optical Technology Co Ltd (5312)?
Earnings per share at Formosa Optical Technology Co Ltd are growing −26.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Formosa Optical Technology Co Ltd (5312) carry?
The net debt of Formosa Optical Technology Co Ltd is 2.5B TWD (fiscal year 2025, ≈ 4.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Formosa Optical Technology Co Ltd in the live analysis

One click puts Formosa Optical Technology Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.